HSF1 and breast cancer: Thus, in the present study, we investigated the hypothesis that downregulation of the heat shock response by gene-editing knockdown of HSF1, or by a specific chemical inhibitor of HSF1: KRIBB11, enhances the therapeutic efficiency of mEHT in breast cancer treatment.